Published in Breast on January 29, 2010
Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma (2007) 2.55
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res (2008) 2.42
Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia. J Clin Oncol (2009) 1.60
Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature. Expert Opin Ther Targets (2010) 1.48
Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis. Med Hypotheses (2004) 1.42
Manipulating the chemokine-chemokine receptor network to treat cancer. Cancer (2007) 1.38
Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer. Med Oncol (2010) 1.16
Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkn's lymphoma patient. World J Gastroenterol (2006) 1.10
Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis. Leuk Lymphoma (2009) 1.09
EGFR expression and gene copy number in triple-negative breast carcinoma. Cancer Genet Cytogenet (2010) 1.08
Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cells. Med Hypotheses (2004) 1.08
Association between common risk factors and molecular subtypes in breast cancer patients. Breast (2012) 1.06
Unusual location of hydatid cyst: soft tissue mass in the neck. Eur Arch Otorhinolaryngol (2006) 1.01
Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors. J Oral Maxillofac Surg (2006) 1.00
Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. Cancer Invest (2007) 1.00
Outcome of non-metastatic male breast cancer: 118 patients. Med Oncol (2011) 0.99
Metastatic granular cell tumor: a case report and review of the literature. Acta Oncol (2006) 0.97
Cardiotoxicity of novel HER2-targeted therapies. Curr Med Res Opin (2013) 0.97
From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures. Eur J Cancer Prev (2008) 0.96
Stem cell-related markers in primary breast cancers and associated metastatic lesions. Mod Pathol (2012) 0.95
Systemic treatment in breast-cancer patients with brain metastasis. Expert Opin Pharmacother (2010) 0.95
A retrospective comparison of robotic stereotactic body radiotherapy and three-dimensional conformal radiotherapy for the reirradiation of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2011) 0.94
A case report: zoledronic acid-induced anterior uveitis. Med Oncol (2007) 0.94
Could the hand-foot syndrome after capecitabine treatment be associated with better outcome in metastatic breast cancer patients? Acta Oncol (2006) 0.94
Pertuzumab in HER2-positive breast cancer. Curr Med Res Opin (2012) 0.94
Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma. Med Oncol (2010) 0.94
Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer. Curr Med Res Opin (2013) 0.93
Iliopsoas muscle injury during a femoral artery puncture: benign but disabling. J Crit Care (2003) 0.92
Metaplastic breast carcinoma: a heterogeneous disease. Asian Pac J Cancer Prev (2014) 0.92
Increased mean platelet volume (MPV) indicating the vascular risk in Alzheimer's disease (AD). Arch Gerontol Geriatr (2011) 0.92
Breast cancer subtypes and outcomes of central nervous system metastases. Breast (2011) 0.92
Zoledronic acid and atrial fibrillation in cancer patients. Support Care Cancer (2010) 0.92
Hormone receptor status in patients with breast cancer and liver metastases treated with laser-induced intersititial thermotherapy. Radiology (2005) 0.91
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer. Breast Cancer Res (2007) 0.91
Anterior abdominal wall synovial sarcoma: a rare presentation. Am J Clin Oncol (2005) 0.91
Effects of haemodialysis and continuous ambulatory peritoneal dialysis on P300 cognitive potentials in uraemic patients. Ups J Med Sci (2004) 0.91
Warfarin-induced skin necrosis and leukocytoclastic vasculitis in a patient with acquired protein C and protein S deficiency. Blood Coagul Fibrinolysis (2007) 0.90
Characteristics of breast cancer patients with central nervous system metastases: a single-center experience. J Natl Med Assoc (2008) 0.90
Brain metastasis of cardiac myxoma: case report and review of the literature. J Neurooncol (2005) 0.90
Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma. Med Oncol (2008) 0.90
Possible association between nanobacteria and malignant microcalcifications in breast cancer. Breast J (2006) 0.89
Orbital metastasis from adenocarcinoma of the colon. South Med J (2005) 0.88
Trastuzumab in metastatic breast cancer after complete remission: How long is enough? Med Oncol (2015) 0.88
Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer. Med Oncol (2010) 0.88
FDG-PET/CT in the evaluation of epithelioid hemangioendothelioma of the liver: the role of dual-time-point imaging. A case presentation and review of the literature. Ann Nucl Med (2010) 0.88
Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients. Oncology (2013) 0.87
Cutaneous metastases of signet cell carcinoma of the rectum without accompanying visceral involvement. South Med J (2006) 0.87
Optimal timing of adjuvant treatment in patients with early breast cancer. Med Oncol (2010) 0.87
Demographic and clinico-pathological characteristics in patients with invasive breast cancer receiving metformin. Med Oncol (2013) 0.86
Ductal carcinoma in situ and bilateral atypical ductal hyperplasia in a 23-year-old man with gynecomastia. Am Surg (2011) 0.86
Treatment and outcomes of Ewing sarcoma in Turkish adults: a single centre experience. Asian Pac J Cancer Prev (2014) 0.86
Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes. Med Oncol (2013) 0.86
Doxorubicin-induced second degree and complete atrioventricular block. Europace (2005) 0.86
Angiotensin-converting enzyme inhibitors for bevacizumab-induced hypertension. Ann Pharmacother (2006) 0.85
Leptin and breast cancer: an overview. Med Oncol (2011) 0.84
Blood ABO groups and risk of breast cancer. Med Oncol (2010) 0.84
Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient. Ann Pharmacother (2005) 0.84
Factors affecting survival in breast cancer patients following bone metastasis. Tumori (2008) 0.84